Dr. David Yang has more than 27 years of experience in the in vitro diagnostic industry. Currently, he is Senior Vice President of Research and Development at Seegene USA, Inc., the US-based division of Seegene Inc. a global developer of infectious disease molecular diagnostic products.
Most recently, David was a Principal Scientist at Danaher Corporation, focused on identifying multimodal detection methodologies to more effective predict and diagnose patients. Earlier in his career, as an associate at Beckman Coulter, he had responsibilities in developing molecular diagnostic systems and life sciences tools, business development and market assessments, resulting in the commercialization of several systems, a number of patents and publications and a multibillion-dollar acquisition. David has a BS from Brooklyn College (Brooklyn, NY) and a PhD in physical chemistry from Emory University (Atlanta, GA).